montelair 4 mg chewable tablets
clonmel healthcare ltd - montelukast - chewable tablet - 4 milligram(s) - leukotriene receptor antagonists; montelukast
saflutan 15 micrograms/ml eye drops, solution, in single-dose container
santen oy - tafluprost - eye drops, solution in single-dose container - 15 micrograms - antiglaucoma preparations and miotics, prostaglandin analogues - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension. as adjunctive therapy to beta-blockers
montelair 5 mg chewable tablets
clonmel healthcare ltd - montelukast - chewable tablet - 5 milligram(s) - leukotriene receptor antagonists; montelukast
melrose plant-sourced glucosamine capsules
melrose laboratories pty ltd - glucosamine hydrochloride, quantity: 750 mg - capsule, hard - excipient ingredients: magnesium stearate; silicon dioxide; ascorbic acid; calcium hydrogen phosphate dihydrate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling
denk-air junior 4mg tablets chewable
denk pharma gmbh & co. kg - montelukast (montelukast sodium) - tablets chewable - 4mg
denk-air junior 5mg tablets chewable
denk pharma gmbh & co. kg - montelukast (montelukast sodium) - tablets chewable - 5mg
denk-air 10mg tablets film-coated
denk pharma gmbh & co. kg - montelukast (montelukast sodium) - tablets film-coated - 10mg
lansoprazole teva 15 mg orodispersible tablets
teva pharma b.v. - lansoprazole - orodispersible tablet - 15 milligram(s) - proton pump inhibitors; lansoprazole
zoton fastab 15 mg oro-dispersible tablets
pfizer healthcare ireland - lansoprazole - orodispersible tablet - 15 milligram(s) - proton pump inhibitors; lansoprazole
singulair 4 mg granules for kiddies
organon pharma israel ltd., israel - montelukast as sodium - granules - montelukast as sodium 4 mg - montelukast - singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma.singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.